Archives 2016

October 27, 2016

Velicept Therapeutics, INC. Names CLARENCE YOUNG, M.D., Chief Medical Officer

October 05, 2016

Velicept Therapeutics Announces FDA Acceptance of IND Application of Novel, Once-daily Formulation of Solabegron for the treatment of Overactive Bladder

March 23, 2016

FDA Approved Cinqair (reslizumab) To Treat Severe Asthma

Please reload

NeXeption

640 Lee Road, Ste 110

Wayne, PA 19087

T +1 484.318.2988

F +1 484.324.7949

Nexeption Logo